BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26853418)

  • 1. Circulating tumor cells in oral squamous cell carcinoma: An insight.
    Prakruthi BV; Babu NC
    Indian J Cancer; 2015; 52(2):232-4. PubMed ID: 26853418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of circulating tumor cells in blood and disseminated tumor cells in bone marrow of patients with squamous cell carcinoma of the oral cavity.
    Gröbe A; Blessmann M; Hanken H; Friedrich RE; Schön G; Wikner J; Effenberger KE; Kluwe L; Heiland M; Pantel K; Riethdorf S
    Clin Cancer Res; 2014 Jan; 20(2):425-33. PubMed ID: 24218516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and clinicopathological significance of circulating tumour cells in patients with oral squamous cell carcinoma.
    Curtin J; Choi SW; Thomson PJ; Lam AK
    Int J Oral Maxillofac Surg; 2022 Mar; 51(3):289-299. PubMed ID: 34154876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.
    Oliveira-Costa JP; de Carvalho AF; da Silveira da GG; Amaya P; Wu Y; Park KJ; Gigliola MP; Lustberg M; Buim ME; Ferreira EN; Kowalski LP; Chalmers JJ; Soares FA; Carraro DM; Ribeiro-Silva A
    Oncotarget; 2015 Aug; 6(25):20902-20. PubMed ID: 26041877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer.
    Woestemeier A; Ghadban T; Riethdorf S; Harms-Effenberger K; Konczalla L; Uzunoglu FG; Izbicki JR; Pantel K; Bockhorn M; Reeh M
    Anticancer Res; 2018 Oct; 38(10):5665-5669. PubMed ID: 30275185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of circulating CD14+/CD16+ monocyte-derived macrophages (MDMs) in the peripheral blood of patients with oral squamous cell carcinoma.
    Grimm M; Feyen O; Coy JF; Hofmann H; Teriete P; Reinert S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Mar; 121(3):301-6. PubMed ID: 26747736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of peripheral blood circulating tumor cells in oral squamous cell carcinoma and its clinical significance.
    Zhang SY; Qin S; Li GH; Yi YQ; Fu HJ; Gao YJ; Sun ML
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2021 Oct; 39(5):591-597. PubMed ID: 34636209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A liquid biopsy for head and neck cancers.
    Schmidt H; Kulasinghe A; Perry C; Nelson C; Punyadeera C
    Expert Rev Mol Diagn; 2016; 16(2):165-72. PubMed ID: 26631411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two methods for the detection of circulating tumour cells in patients with oral cavity cancer.
    Curtin J; Wong G; Wang W; Thomson P; Lam AK; Choi SW
    J Oral Pathol Med; 2022 Mar; 51(3):249-255. PubMed ID: 34586677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
    Jiang T; Xie P; Liu H
    J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of circulating tumor cells as a promising method of genitourinary cancer diagnosis].
    Gurtowska N; Bajek A; Olkowska J; Drewa T
    Postepy Hig Med Dosw (Online); 2012 Dec; 66():983-90. PubMed ID: 23687217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells in breast cancer--current status and perspectives.
    Banys-Paluchowski M; Krawczyk N; Meier-Stiegen F; Fehm T
    Crit Rev Oncol Hematol; 2016 Jan; 97():22-9. PubMed ID: 26563820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of clustered circulating tumor cells (CTCs) and circulating cytokines define an aggressive phenotype in metastatic colorectal cancer.
    Divella R; Daniele A; Abbate I; Bellizzi A; Savino E; Simone G; Giannone G; Giuliani F; Fazio V; Gadaleta-Caldarola G; Gadaleta CD; Lolli I; Sabbà C; Mazzocca A
    Cancer Causes Control; 2014 Nov; 25(11):1531-41. PubMed ID: 25135616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma.
    Choi MK; Kim GH; I H; Park SJ; Lee MW; Lee BE; Park DY; Cho YK
    J Gastroenterol Hepatol; 2019 Mar; 34(3):552-560. PubMed ID: 30426559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of circulating cancer cells in human oral squamous cell carcinoma.
    Zen H; Nakashiro K; Shintani S; Sumida T; Aramoto T; Hamakawa H
    Int J Oncol; 2003 Sep; 23(3):605-10. PubMed ID: 12888894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients.
    Wu C; Hao H; Li L; Zhou X; Guo Z; Zhang L; Zhang X; Zhong W; Guo H; Bremner RM; Lin P
    J Thorac Oncol; 2009 Jan; 4(1):30-6. PubMed ID: 19096303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.
    Su CW; Su BF; Chiang WL; Yang SF; Chen MK; Lin CW
    Int J Med Sci; 2017; 14(1):37-44. PubMed ID: 28138307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematogenous cytokeratin 20 mRNA detection has prognostic impact in oral squamous cell carcinoma: preliminary results.
    Toyoshima T; Vairaktaris E; Nkenke E; Schlegel KA; Neukam FW; Ries J
    Anticancer Res; 2009 Jan; 29(1):291-7. PubMed ID: 19331164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.